NewsRx

Search our medical news database

Alter-G Inc.

Alter-G Announces $2.5 Million Round of Funding

Published in Healthcare Finance, Tax and Law Weekly, July 16th, 2008

Alter-G, Inc., developers of the innovative G-Trainer anti-gravity treadmill, announced an agreement with a group of current and new investors providing a combined $2.5 million in Series A1 capital funding.

Key investors include Frog & Peach Investments of San Francisco, CA, Astrolabe Ventures of Palo Alto, CA, and Funk Ventures of Santa Monica, CA.

"We are pleased with the confidence our investors place in our significant opportunity and their trust in management's ability to execute," said Lars Barfod, CEO of Alter-G. "Over the past year we have substantially validated our technology, product and target markets. We will use the funds to expand...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook